Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma

The American Journal of Medicine

Volumn 79, Issue 6 SUPPL. 1, 1985, Pages 62-66

  Busse, William W ^a   Bush, Robert K ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; PLACEBO; THEOPHYLLINE;

ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG THERAPY; HUMAN; NOCTURNAL ASTHMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SUSTAINED RELEASE PREPARATION; THERAPY;

ADULT; APPETITE; ASTHMA; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGE; NAUSEA; PEAK EXPIRATORY FLOW RATE; THEOPHYLLINE;

EID: 0022345890     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(85)90091-9     Document Type: Article

References (15)

1. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hour preparation
2. The relation of product formulation to absorption of oral theophylline
3. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children
4. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma
5. Sustained-release theophylline: a significant advance in the treatment of childhood asthma
6. Does sleep cause nocturnal asthma?
7. Comparison of the effects of theophylline, prednisolone and sleep withdrawal on airway obstruction and urinary cyclic AMP/cyclic GMP excretion of asthmatic children with and without nocturnal asthma
8. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol
9. Histamine and nocturnal wheezing
10. Nocturnal asthma: features of attacks, sleep and breathing patterns
11. The pharmacology and therapeutic use of theophylline
12. Temporal variations in trough serum theophylline concentrations at steady-state
13. Sustained release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics
14. The relative bioavailability of a controlled-release theophylline formulation after multiple doses
15. Theophylline: a “state of the art” review